CAMP and type 1 diabetes mellitus: Sun et al. [153] showed that activation of FFAR2 signaling increases cathelicidin-related antimicrobial peptide (CRAMP) production from pancreatic endocrine cells as protection against type 1 diabetes (T1D) [153].